dc.contributor.author | Gurses, Candan | |
dc.contributor.author | Orhan, Elif | |
dc.contributor.author | Atmaca, Murat Mert | |
dc.contributor.author | Bebek, Nerses | |
dc.date.accessioned | 2021-03-03T18:54:12Z | |
dc.date.available | 2021-03-03T18:54:12Z | |
dc.identifier.citation | Atmaca M. M. , Orhan E., Bebek N., Gurses C., "Intravenous levetiracetam treatment in status epilepticus: A prospective study", EPILEPSY RESEARCH, cilt.114, ss.13-22, 2015 | |
dc.identifier.issn | 0920-1211 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_519eda69-0eb9-463d-869a-673f0061b7ce | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/58009 | |
dc.identifier.uri | https://doi.org/10.1016/j.eplepsyres.2015.04.003 | |
dc.description.abstract | Objective: To assess the efficacy of intravenous (IV) levetiracetam (LEV) in the treatment of status epilepticus (SE) and treatment outcomes. | |
dc.language.iso | eng | |
dc.subject | Neurology | |
dc.subject | Neurology (clinical) | |
dc.subject | Life Sciences | |
dc.subject | Health Sciences | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Nöroloji | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Tıp | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | KLİNİK NEUROLOJİ | |
dc.title | Intravenous levetiracetam treatment in status epilepticus: A prospective study | |
dc.type | Makale | |
dc.relation.journal | EPILEPSY RESEARCH | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 114 | |
dc.identifier.startpage | 13 | |
dc.identifier.endpage | 22 | |
dc.contributor.firstauthorID | 86735 | |